Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 91.20
+1.10 (1.22%)
Aug 7, 2026, 9:49 AM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 15.09 billion as of August 6, 2026. Its market cap has decreased by -33.79% in one year.
Market Cap
15.09B
Enterprise Value
14.36B
Revenue
31.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
91.20
ChartMarket Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 15.09B, an increase of 251.36%. That is a compound annual growth rate of 12.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 15.09B | -53.94% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.93B |
| Sunmax Biotechnology | 21.13B |
| Medigen Vaccine Biologics | 17.13B |
| TaiMed Biologics | 16.15B |
| Ever Supreme Bio Technology | 15.27B |
| ACRO Biomedical | 14.96B |
| EirGenix | 14.74B |
| Tanvex BioPharma | 10.06B |